East Money Securities·2025-11-10 08:51Investment Rating - The report initiates coverage with an "Accumulate" rating for China Life Insurance [2][3]. Core Insights - China Life Insurance's performance in the first three quarters of 2025 continues to show high-quality development, with core indicators such as profitability, business, investment, and risk control demonstrating steady optimization. The synergy between assets and liabilities, along with a focus on equity investments, forms the core support for growth, characterized by stable growth in scale, optimized structure, improved efficiency, and controllable risks [2][7]. - The company achieved a revenue of 537.9 billion yuan in the first three quarters of 2025, representing a year-on-year increase of 25.9%. The net profit attributable to shareholders reached 167.8 billion yuan, up 60.5% year-on-year, with a significant quarterly increase of 91.5% in Q3, primarily due to improved investment returns from the equity market [7]. - The total premium income for the first three quarters of 2025 was 669.645 billion yuan, a year-on-year increase of 10.1%, marking a historical high for the same period. New policy premiums and renewal premiums both grew by 10.4% and 10.0%, respectively, achieving the highest growth rates since 2021 [7]. - The sales force remains robust, with a total of 657,000 sales personnel as of September, maintaining the industry's leading position. The professionalization and retention rates of the sales team have significantly improved, providing solid support for sustained business growth [7]. - The investment performance is strong, with total investment income reaching 368.551 billion yuan, a year-on-year increase of 41.0%. The total investment return rate was 6.42%, up 104 basis points year-on-year, with equity assets becoming the core contributor to investment income growth [7]. - As of September, total assets amounted to 74,179.81 billion yuan, a 9.6% increase from the beginning of the year, with net assets attributable to shareholders growing by 22.8% year-on-year. The solvency ratios remain robust, ensuring compliance with regulatory requirements [7]. Financial Projections - The projected net profit attributable to shareholders for 2025, 2026, and 2027 is estimated at 170.654 billion yuan, 175.587 billion yuan, and 181.327 billion yuan, respectively, with year-on-year growth rates of 59.6%, 2.9%, and 3.3% [2][8]. - The expected revenue for 2025 is 603.254 billion yuan, reflecting a year-on-year growth of 14.1% [8].